(Q35000978)

English

Fluvastatin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

Fluvastatin. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Lawrence JM

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Reckless JP

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Expert Opinion on Pharmacotherapy

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1631-1641

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Pharmacokinetics of fluvastatin in subjects with renal impairment and nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Safety, tolerability, and pharmacokinetics of an extended-release formulation of fluvastatin administered once daily to patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A.

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Frequency of creatine kinase elevation during treatment with fluvastatin

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Cerivastatin and reports of fatal rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

HMG-CoA reductase inhibitors and myotoxicity

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Non-lipid-related effects of statins

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Fluvastatin: effects beyond cholesterol lowering

1 reference

https://api.crossref.org/works/10.1517%2F14656566.3.11.1631

21 January 2018

Identifiers

10.1517/14656566.3.11.1631

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35000978&oldid=1983993677"